Bar Harbor Wealth Management Has $7.34 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Bar Harbor Wealth Management trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% in the 3rd quarter, Holdings Channel.com reports. The fund owned 12,545 shares of the healthcare conglomerate’s stock after selling 248 shares during the quarter. Bar Harbor Wealth Management’s holdings in UnitedHealth Group were worth $7,335,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the third quarter worth approximately $27,000. Macroview Investment Management LLC lifted its position in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Delos Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares during the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth $31,000. Finally, Global Wealth Strategies & Associates raised its stake in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.9 %

NYSE UNH opened at $566.00 on Friday. The stock’s 50-day moving average is $584.20 and its 200-day moving average is $533.07. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $608.63. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The firm has a market cap of $522.66 billion, a P/E ratio of 37.53, a P/E/G ratio of 1.69 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the prior year, the business earned $6.56 EPS. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Analyst Ratings Changes

UNH has been the topic of several research reports. Cantor Fitzgerald boosted their price target on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday. Bank of America reduced their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday. Morgan Stanley cut their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday. TD Cowen boosted their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $615.16.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.